ILC3 deficiency and generalized ILC abnormalities in DOCK8‐deficient patients. Issue 4 (31st October 2019)

• Record Type: Journal Article
• Authors: Eken, Ahmet; Cansever, Murat; Okus, Fatma Zehra; Erdem, Serife; Nain, Ercan; Azizoglu, Zehra Busra; Haliloglu, Yesim; Karakukcu, Musa; Ozcan, Alper; Devecioglu, Omer; Aksu, Guzide; Arikan Ayyildiz, Zeynep; Topal, Erdem; Karakoc Aydiner, Elif; Kiykim, Ayca; Metin, Ayse; Cipe, Funda; Kaya, Aysenur; Artac, Hasibe; Reisli, Ismail; Guner, Sukru N.; Uygun, Vedat; Karasu, Gulsun; Dönmez Altuntas, Hamiyet; Canatan, Halit; Oukka, Mohamed; Ozen, Ahmet; Chatila, Talal A.; Keles, Sevgi; Baris, Safa; Unal, Ekrem; Patiroglu, Turkan;
• Is Part Of: Allergy. Volume 75:Issue 4(2020)
• Page Start: 921
• Page End: 932
• Publication Date: 2019-10-31
• Subjects: DOCK8 -- Hyper‐IgE syndrome (HIES) -- ILC -- ILC3 -- STAT3; Allergy -- Periodicals; 616.97
• DOI: 10.1111/all.14081
• Languages: English
• ISSNs: 0105-4538

Abstract

Abstract: Background: Dedicator of cytokinesis 8 (DOCK8) deficiency is the main cause of the autosomal recessive hyper‐IgE syndrome (HIES). We previously reported the selective loss of group 3 innate lymphoid cell (ILC) number and function in a Dock8 ‐deficient mouse model. In this study, we sought to test whether DOCK8 is required for the function and maintenance of ILC subsets in humans. Methods: Peripheral blood ILC1‐3 subsets of 16 DOCK8‐deficient patients recruited at the pretransplant stage, and seven patients with autosomal dominant (AD) HIES due to STAT3 mutations, were compared with those of healthy controls or post‐transplant DOCK8‐deficient patients (n = 12) by flow cytometry and real‐time qPCR. Sorted total ILCs from DOCK8‐ or STAT3‐mutant patients and healthy controls were assayed for survival, apoptosis, proliferation, and activation by IL‐7, IL‐23, and IL‐12 by cell culture, flow cytometry, and phospho‐flow assays. Results: DOCK8‐deficient but not STAT3‐mutant patients exhibited a profound depletion of ILC3s, and to a lesser extent ILC2s, in their peripheral blood. DOCK8‐deficient ILC1‐3 subsets had defective proliferation, expressed lower levels of IL‐7R, responded less to IL‐7, IL‐12, or IL‐23 cytokines, and were more prone to apoptosis compared with those of healthy controls. Conclusion: DOCK8 regulates human ILC3 expansion and survival, and more globally ILC cytokine signaling and proliferation. DOCK8 deficiency leads to loss of ILC3 from peripheral blood. ILC3 deficiency may contribute to the susceptibility of DOCK8‐deficient patients to infections. Abstract : Peripheral blood ILC3 and ILC2s are reduced in DOCK8 but not STAT3 mutant HIES patients. DOCK8 deficient human ILCs have reduced IL‐7 receptor expression, impaired IL‐7, IL‐23 and IL‐12 signaling and are more prone to apoptosis. DOCK8 is required for maintenance and function of human peripheral blood ILC3s. ILC3 depletion may contribute to susceptibility of DOCK8 deficient patients to infections.